Foundations Investment Advisors LLC slashed its position in Intuitive Surgical by 93.3% during the third quarter, reducing its holdings from 40,610 shares to just 2,715 shares. This divestiture involved the sale of 37,895 shares and brought the firm’s post-sale stake to a valuation of approximately $1.21 million as reported in its latest SEC filing. Such a steep reduction from a previously substantial position signals a significant shift in the portfolio allocation of this advisory group.

Several other institutional investors adjusted their Intuitive Surgical exposure in the same period. Strategic Advisors LLC expanded its stake by 63.3%, adding 4,031 shares to reach 10,397 shares valued at roughly $4.65 million. AE Wealth Management increased its position by 18.9%, acquiring 1,836 shares for a total of 11,556 shares. LRI Investments LLC and Birchbrook Inc. also boosted holdings by 24.0% and 5.1%, respectively, while Activest Wealth Management added 20 shares for a 21.7% gain. Overall, institutional and hedge fund ownership stands at 83.64%.

In its latest quarterly report, Intuitive Surgical delivered earnings per share of $2.53, surpassing consensus estimates by $0.26. Revenue climbed to $2.87 billion, an 18.8% year-over-year increase that topped analysts’ projection by $150 million. The company achieved a net margin of 28.38% and a return on equity of 15.06%, reflecting continued operational leverage in its core robotic surgical systems business.

Research firms have updated their outlook on Intuitive Surgical over recent months. Two analysts now rate the stock as a ‘Strong Buy,’ fourteen maintain a ‘Buy’ stance and eight hold ‘Neutral’ assessments. One analyst issues a ‘Sell’ recommendation. Consensus target estimates average out to approximately $620—up from the prior consensus—as several firms have raised targets by as much as $50, while a smaller number have trimmed objectives by up to $45.